Spirair, Inc.
PrivateLast Round
Series B
Aug 12, 2025
Total Funding Raised
$22.8M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Spirair, Inc. operates in Healthcare & Life Sciences and is based in South San Francisco, California. Its latest recorded funding round was a Series B round in August 2025.
Spirair, Inc. is a medical device company that develops minimally invasive solutions for otolaryngologists to improve patient care for nasal obstruction.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Spirair, Inc. Comparables
Compare Spirair, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Aerin Medical | 80% | |
| Stryker Corporation | 79% | |
| Medtronic | 77% |
For institutional investors. Book with your work email.
Spirair, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Aug 12, 2025 | ||||
| Series B | Jul 28, 2025 | ||||
| Series A | Aug 1, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Spirair, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Cadence Healthcare Ventures | Series B |
| View Ventures | Series A, Series B |
| 1809 Capital | Series B |
| Sonder Capital | Series A, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 28, 2026
Grew 23% QoQ, from 26 to 32 employees.
- Jul 20, 2026
Open roles increased to 8, 2.1x the trailing average.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- launchesOct 13, 2026
Spirair, Inc. announces the release of an updated SeptAlign(R), an FDA-cleared, minimally invasive, cartilage-preserving septoplasty technology with stronger anchoring, greater placement precision, and improved ergonomics, in California on Oct 13th '26.
For institutional investors. Book with your work email.
Spirair, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Spirair, Inc.'s valuation, stock price, and market status.
Is Spirair, Inc. a public or private company?
Spirair, Inc. is a private company.
What is the current stock price of Spirair, Inc.?
Spirair, Inc. is a private company, so its shares have no public market price. Caplight tracks Spirair, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Spirair, Inc. worth (valuation)?
Valuation information for Spirair, Inc. is not publicly available.
Can I buy Spirair, Inc. stock?
Spirair, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Spirair, Inc.'s last funding round?
Spirair, Inc.'s most recent funding round was Series B on August 12, 2025.
Who are the main investors in Spirair, Inc.?
Key investors in Spirair, Inc. include View Ventures, Sonder Capital.
Will Spirair, Inc. IPO soon?
No public IPO plans have been announced for Spirair, Inc..
How can I track Spirair, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Spirair, Inc.'s shares on secondary markets.